Form 4 for KTTA Pasithea Therapeutics Corp.
Accepted 2022-10-21 00:00:00 ET · period of report 2022-10-21 · accession 0001213900-22-065571 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-10-21 | 2022-10-21 | KTTA | Marques Tiago | CEO, Dir | A - Grant | $1.07 | +5,000 | 805.6K | +0.6% | +$5,356 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-21 | A | A | 4,400 | $1.07 | 810,000 | D | — | — | |
| 2 | Common | Common Stock | 2022-10-21 | A | A | 600 | $1.08 | 805,600 | D | — | — |